Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study

被引：0
|
作者：
de Valk, Harold W.
Feher, Michael
Hansen, Troels K.
Jendle, Johan H.
Merchante, Angel
Koefoed, Mette M.
Rizi, Ehsan Parvaresh
Zimmermann, Esther
Fadini, Gian Paolo
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-374-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374-P
引用
收藏
页数：3
相关论文
共 29 条
  • [1] Hypoglycaemia, irrespective of the definition used, is reduced when switching to insulin degludec from other basal insulins in routine clinical care: the ReFLeCT study
    Feher, M. D.
    Fadini, G. P.
    Hansen, T. Krarup
    Jendle, J.
    Merchante, A.
    Koefoed, M. M.
    Rizi, E. Parvaresh
    Zimmermann, E.
    de Valk, H. W.
    [J]. DIABETOLOGIA, 2019, 62 : S385 - S385
  • [2] Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study
    de Valk, Harold W.
    Feher, Michael
    Hansen, Troels K.
    Jendle, Johan H.
    Merchante, Angel
    Koefoed, Mette M.
    Rizi, Ehsan Parvaresh
    Zimmermann, Esther
    Fadini, Gian Paolo
    [J]. DIABETES, 2019, 68
  • [3] Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
    Fadini, Gian Paolo
    Feher, Michael
    Hansen, Troels Krarup
    de Valk, Harold W.
    Koefoed, Mette Marie
    Wolden, Michael
    Zimmermann, Esther
    Jendle, Johan
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (12): : 5977 - 5990
  • [4] Clinical Utility of Switching to Insulin Degludec from Other Basal Insulins in Patients with Type 1 or 2 Diabetes
    Baran, O.
    Dersch-Mills, D.
    Bakal, J.
    Arbo, T.
    Hnatiuk, M.
    Roedler, R.
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2021, 74 (02): : 185 - 185
  • [5] Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
    Harold W. de Valk
    Michael Feher
    Troels Krarup Hansen
    Johan Jendle
    Mette Marie Koefoed
    Ehsan Parvaresh Rizi
    Esther Zimmermann
    Gian Paolo Fadini
    [J]. Diabetes Therapy, 2020, 11 : 2159 - 2167
  • [6] Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
    de Valk, Harold W.
    Feher, Michael
    Hansen, Troels Krarup
    Jendle, Johan
    Koefoed, Mette Marie
    Rizi, Ehsan Parvaresh
    Zimmermann, Esther
    Fadini, Gian Paolo
    [J]. DIABETES THERAPY, 2020, 11 (09) : 2159 - 2167
  • [7] Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study
    Fadini, Gian Paolo
    Giordano, Carla
    Salvi, Laura
    Nicolucci, Antonio
    [J]. DIABETES THERAPY, 2020, 11 (12) : 2909 - 2920
  • [8] Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study
    Gian Paolo Fadini
    Carla Giordano
    Laura Salvi
    Antonio Nicolucci
    [J]. Diabetes Therapy, 2020, 11 : 2909 - 2920
  • [9] Clinical Utility of Switching to Insulin Degludec From Other Basal Insulins in Adult Patients With Type 1 or Type 2 Diabetes
    Baran, Oleksandr
    Dersch-Mills, Deonne
    Bakal, Jeffrey A.
    Huyghebaert, Trudy
    Hnatiuk, Melanie
    Roedler, Rhonda L.
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (04) : 381 - +
  • [10] Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data
    Landstedt-Hallin, Lena
    Gundgaard, Jens
    Ericsson, Asa
    Ellfors-Zetterlund, Susanne
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 647 - 655
123